跳至主要内容
临床试验/NCT01427335
NCT01427335已完成3 期

Does Intravenous Calcium Infusion Effectively Prevent OHSS : a Randomised Controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
200
试验地点
1
主要终点
OHSS rate

研究概览

简要总结

There are many protocols for prevention of ovarian hyperstimulation syndrome, intravenous calcium is a novel protocol. But still there is lack of evidence of it is real effect in prevention of OHSS & the mechanism of its action is still questionable . In the study the investigators try to search for the evidence for its effect & the real mechanism for its action.

详细描述

The study population will be divided into 2groups each containing 100 infertile couples candidate for ICSI.

Group (A)active group: administration of 10% Intravenous calcium gluconate 10 ml in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup. Intravenous infusion was performed within 30 minutes.

Group (B): placebo group: administration of 200 mL of 0.9% saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup. Intravenous infusion was performed within 30 minutes

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • infertile women aged 20 to 38 years.
  • BMI ranged from 18 to
  • serum FSH within normal limits( 1-12IU /l)
  • presented with ovarian response suggestive of being at risk of developing OHSS because of the presence of at least 15 follicles of 10 mm or greater on the day of hCG administration.

排除标准

  • endocrinopathies.
  • a systemic disease.
  • using any medication (e.g., insulin-sensitizing drugs and GnRH antagonists.
  • patients need coasting for high risk of OHSS.
  • patients need cycle cancellation.
  • severe male infertility requiring testicular sperm extraction.

研究组 & 干预措施

saline

Placebo Comparator

0.9% saline intravenous infusion

干预措施: 0.9 % saline (Drug)

calcium

Experimental

Calcium intravenous infusion

干预措施: calcium (Drug)

结局指标

主要结局

OHSS rate

时间窗: 2 years

ovarain hyperstimulation syndrome

次要结局

  • clinical pregnancy rate(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Waleed El-khayat

Doctor

Cairo University

研究点 (1)

Loading locations...

相似试验

Calcium for Prevention of Ovarian Hyperstimulation... | 临床试验